The Oil & Gas Journal, first published in 1902, is the world's most widely read petroleum industry publication. OGJ delivers international oil and gas industry news; analysis of issues and events; practical technology for design, operation, and maintenance of oil and gas operations; and important statistics on energy markets and industry activity.

OGJ is edited to meet the needs of engineers, geoscientists, managers, and executives throughout the oil and gas industry. It is part of Endeavor Business Media, Nashville, Tenn., which also publishes Offshore Magazine.

Endeavor Business Media’s Petroleum Group also produces targeted e-Newsletters; hosts global conferences and exhibitions, seminars, and forums; and publishes directories, technical books, print and electronic databases, surveys, and maps.

Additional Information

Website & Technical Help

For help with subscription purchases or refunds, or trouble logging into the paid subscription content on www.ogj.com, please contact Customer Service at [email protected] or call 1-847-559-7598.

For more customer service information, please click here.

ADAP Advocacy Airs Commercial Highlighting Growing Medical Debt Crisis Being Fueled by 340B-Eligible Hospitals & Predatory Debt Collection





Commercial: Is the 340B Drug Pricing Program the Next 'Too Big to Fail'?

WASHINGTON, DC, August 19, 2025 /24-7PressRelease/ -- ADAP Advocacy today, as part of its 340B Project, aired its latest commercial calling for reforms to the 340B Drug Pricing Program. The commercial highlights the growing medical debt crisis, asking a critical question: "Is the 340B Drug Pricing Program the Next 'Too Big to Fail'?".

Brandon M. Macsata, CEO of ADAP Advocacy, summarized: "Hospitals eligible to participate in the 340B Drug Pricing Program, many of them so-called nonprofit hospitals, are choosing not to set reasonable prices and offer robust financial assistance to help poor patients. They sue their patients, often with predatory debt collection, rather than provide free charity care, as is required by law. The 340B Program was designed to help patients, not pad the pockets of these healthcare providers."

Macsata noted the recent patient perspectives survey on medical debt, commissioned by ADAP Advocacy, which found that nearly four out of five patients delayed or avoided medical care due to inability to pay (excluding the purchase of prescription drugs), and three-fourths of patients held medical debt.

The new commercial is part of the '340B Too Big To Fail' national advocacy campaign, which will run through the end of the year, highlighting hospitals' declining charity, rising healthcare executive compensation, and exploding patient medical debt, among some other issues.

The commercial is available online at https://youtu.be/pxOhzEqzuQA.

To learn more about ADAP Advocacy, 340B Drug Pricing Program, medical debt, or the new 340B commercial, please email info@adapadvocacy.org.

About ADAP Advocacy: ADAP Advocacy's mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS. ADAP Advocacy works with advocates, community, health care, government, patients, pharmaceutical companies, and other stakeholders to raise awareness, offer patient educational programs, and foster greater community collaboration.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.